Extension of the study on COVID-19 booster in pregnant and lactating women
20.10.2022 - The study on safety monitoring of COVID-19 vaccines in pregnant and lactating women, called the "Covid Vaccine Monitor" study, has been extended until end of November 2022.
The primary objective of this study is to generate and compare incidence rates of adverse reactions of different COVID-19 vaccines reported in pregnant and lactating women, through online questionnaires.
It is a Swiss observational study which is associated with a large European study on COVID-19 vaccines in general and special populations (pregnant and lactating women, children and adolescents, immunocompromised people…), sponsored by the European Medicines Agency (EMA).
Pregnant and lactating women who have been vaccinated with a first, second or third booster in the last 48 hours can register for this study at: http://www.covidvaccinemonitor.eu